U.S., April 9 -- ClinicalTrials.gov registry received information related to the study (NCT07518238) titled 'Hernia Abd Wall Recons - BDE vs Exparel' on April 02.
Brief Summary: This trial compares how two different numbing medications help patients feel the least amount of pain while recovering from surgery.
Study Start Date: Jan. 13
Study Type: INTERVENTIONAL
Condition:
BDE for Hernia Patients
Exparel for Hernia Patients
Intervention:
DRUG: BDE Injectable Drug
Bupivacaine, Dexamethasone, Epinephrine for hernia patients receiving abdominal wall reconstruction
DRUG: Exparel Injectable Drug
Exparel for hernia patients receiving abdominal wall reconstruction
Recruitment Status: ENROLLING_BY_INVITATION
Sponsor: Baylor Research Inst...